Feasibility, Outcomes, and Safety of Telehepatology Services During the COVID‐19 Pandemic

Nipun Verma, Saurabh Mishra, Surender Singh, Rajwant Kaur, Talwinder Kaur, Arka De, Madhumita Premkumar, Sunil Taneja, Ajay Duseja, Meenu Singh, Virendra Singh – 20 April 2021 – Coronavirus disease 2019 (COVID‐19) has hampered health care delivery globally. We evaluated the feasibility, outcomes, and safety of telehepatology in delivering quality care amid the pandemic. A telemedicine setup using smartphones by hepatologists was organized at our tertiary‐care center after pilot testing. Consecutive patients availing telehepatology services were recruited between March and July 2020.

Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death‐Ligand 1 Blockade Responses

Jihoon G. Yoon, Min Hwan Kim, Mi Jang, Hoguen Kim, Ho Kyoung Hwang, Chang Moo Kang, Woo Jung Lee, Beodeul Kang, Choong‐kun Lee, Min Goo Lee, Hyun Cheol Chung, Hye Jin Choi, Young Nyun Park – 20 April 2021

Subscribe to